Allowability of IR&D Costs: Dis-inflation Run Amok
Client Alert | less than 1 min read | 03.09.11
DOD has issued a proposed amendment to DFARS 231.205-18 (Mar. 2, 2011) that would condition the allowability of independent research and development costs on the reporting of unspecified information about individual projects at least annually and again on completion of projects, using DOD on-line reporting forms. The proposed rule would apply to all contractors with annual IR&D costs in excess of $50,000, an amount that is less than 1% of the threshold in effect in 1990 for reporting IR&D projects under the prior regulatory regime, a mandatory reporting requirement that was completely abolished in 1996.
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
